Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejection

Charles F. Shield, Lawrence Kahana, John Pirsch, Pedro Vergne-Marini, M. Roy First, Timothy J. Schroeder, David Cohen, Douglas J. Norman, Anthony Monaco, Arturo Martinez, Charles A. Dinarello, Jennifer Dehlinger, Shu Chen H. Wu, Allan Van Horn

Research output: Contribution to journalComment/debate

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)164-166
Number of pages3
JournalTransplantation
Volume54
Issue number1
DOIs
StatePublished - Jul 1992

ASJC Scopus subject areas

  • Transplantation

Cite this

Shield, C. F., Kahana, L., Pirsch, J., Vergne-Marini, P., First, M. R., Schroeder, T. J., Cohen, D., Norman, D. J., Monaco, A., Martinez, A., Dinarello, C. A., Dehlinger, J., Wu, S. C. H., & Van Horn, A. (1992). Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejection. Transplantation, 54(1), 164-166. https://doi.org/10.1097/00007890-199207000-00030